Literature DB >> 10639528

Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1.

J J Yim1, G Y Park, C T Lee, Y W Kim, S K Han, Y S Shim, C G Yoo.   

Abstract

BACKGROUND: Although smoking is the major causal factor in the development of chronic obstructive pulmonary disease (COPD), only 10-20% of chronic heavy cigarette smokers develop symptomatic COPD which suggests the presence of genetic susceptibility. This genetic susceptibility to COPD might depend on variations in enzyme activities that detoxify cigarette smoke products such as microsomal epoxide hydrolase (mEPHX) and glutathione-S transferase (GST). As there is increasing evidence that several genes influence the development of COPD, multiple gene polymorphisms should be investigated to find out the genetic susceptibility to COPD.
METHODS: The genotypes of 83 patients with COPD and 76 healthy smoking control subjects were determined by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (PCR-RFLP) for the mEPHX gene, and multiplex PCR for GST M1 and GST T1 genes. The frequencies of polymorphic genotypes of mEPHX, GST M1, and GST T1 genes were compared both individually and in combination in patients with COPD and healthy smokers.
RESULTS: No differences were observed in the frequency of polymorphic genotypes in exons 3 and 4 of mEPHX, GST M1, and GST T1 genes between patients with COPD and healthy smokers. The frequencies of any combination of these genotypes also showed no differences between the COPD group and the control group.
CONCLUSIONS: Genetic polymorphisms in mEPHX, GST M1, and GST T1 genes are not associated with the development of COPD in Koreans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639528      PMCID: PMC1745681          DOI: 10.1136/thorax.55.2.121

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer.

Authors:  D J Harrison; A M Cantlay; F Rae; D Lamb; C A Smith
Journal:  Hum Exp Toxicol       Date:  1997-07       Impact factor: 2.903

2.  Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung.

Authors:  A M Cantlay; C A Smith; W A Wallace; P L Yap; D Lamb; D J Harrison
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

3.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors:  T Sveger
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

4.  Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks.

Authors:  C L Chen; Q Liu; M V Relling
Journal:  Pharmacogenetics       Date:  1996-04

5.  Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.

Authors:  C A Smith; D J Harrison
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

6.  Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset.

Authors:  G Chenevix-Trench; J Young; M Coggan; P Board
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

7.  Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta.

Authors:  H H Nelson; J K Wiencke; D C Christiani; T J Cheng; Z F Zuo; B S Schwartz; B K Lee; M R Spitz; M Wang; X Xu
Journal:  Carcinogenesis       Date:  1995-05       Impact factor: 4.944

8.  Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect.

Authors:  H Chen; D P Sandler; J A Taylor; D L Shore; E Liu; C D Bloomfield; D A Bell
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

9.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.

Authors:  C Hassett; L Aicher; J S Sidhu; C J Omiecinski
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

10.  Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci.

Authors:  J Elexpuru-Camiruaga; N Buxton; V Kandula; P S Dias; D Campbell; J McIntosh; J Broome; P Jones; A Inskip; J Alldersea
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

View more
  24 in total

1.  Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis.

Authors:  Hong Xue; Jian Su; Kai Sun; Weiping Xie; Hong Wang
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

2.  Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.

Authors:  Craig P Hersh; Dawn L Demeo; Christoph Lange; Augusto A Litonjua; John J Reilly; David Kwiatkowski; Nan Laird; Jody S Sylvia; David Sparrow; Frank E Speizer; Scott T Weiss; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-07       Impact factor: 6.914

3.  Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.

Authors:  J Y Park; L Chen; A Elahi; P Lazarus; M S Tockman
Journal:  Eur J Cancer Prev       Date:  2005-06       Impact factor: 2.497

4.  Genetic association analysis of functional impairment in chronic obstructive pulmonary disease.

Authors:  Craig P Hersh; Dawn L Demeo; Ross Lazarus; Juan C Celedón; Benjamin A Raby; Joshua O Benditt; Gerard Criner; Barry Make; Fernando J Martinez; Paul D Scanlon; Frank C Sciurba; James P Utz; John J Reilly; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

5.  Genetic susceptibility to ischemic cerebrovascular disease in Koreans.

Authors:  Jae-Young Um; Nyeon-Hyoung An; Sang-Hun Kim; Kang-Min Lee; Yo-Sik Kim; Hyuk Jang; Kwang-Ho Cho; Byung-Soon Moon; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

6.  Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population.

Authors:  Hitender Thakur; Lipsy Gupta; Ranbir C Sobti; Ashok K Janmeja; Amlesh Seth; Sharwan K Singh
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

Review 7.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

9.  Genetic determinants of emphysema distribution in the national emphysema treatment trial.

Authors:  Dawn L DeMeo; Craig P Hersh; Eric A Hoffman; Augusto A Litonjua; Ross Lazarus; David Sparrow; Joshua O Benditt; Gerard Criner; Barry Make; Fernando J Martinez; Paul D Scanlon; Frank C Sciurba; James P Utz; John J Reilly; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2007-03-15       Impact factor: 21.405

Review 10.  Genetics of chronic obstructive pulmonary disease.

Authors:  Carola Seifart; Alexandra Plagens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.